Effect of Music Therapy on Patients Undergoing Intravitreal Injections
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00702039|
Recruitment Status : Completed
First Posted : June 19, 2008
Last Update Posted : January 17, 2018
Multiple studies in various specialties, including ophthalmology, are reported in the literature that show that playing music during a procedure (dubbed music therapy) increases patient satisfaction and may reduce patient anxiety and stress levels.
There is no study in the literature that assesses the effects of listening to music in patients undergoing intravitreal injections. This study aims to assess whether listening to music improves patient satisfaction or reduces their anxiety levels in subjects undergoing intravitreal injections.
|Condition or disease||Intervention/treatment|
|Intravitreal Injections Patient Satisfaction Patient Anxiety||Other: No Music Other: Music Therapy|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Effect of Music Therapy on Patients Undergoing Intravitreal Injections|
|Study Start Date :||February 2007|
|Primary Completion Date :||February 2009|
|Study Completion Date :||June 2011|
Those patients receiving intravitreal injections who will be listening to classical music during injection.
Other: Music Therapy
Classical music being played during intravitreal injection.
Those patients receiving intravitreal injections who will not be listening to any music during injection.
Other: No Music
No music will be played in patients in arm 2 of the study.
- This study aims to assess what affects music therapy has on patients receiving intravitreal injections. The subject will take a Satisfaction Survey after the procedure and an Anxiety Survey before and after the injection. [ Time Frame: Before and after the subject's intravitreal injection. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00702039
|United States, Connecticut|
|Yale Eye Center|
|New Haven, Connecticut, United States, 06510|
|Principal Investigator:||Ron Adelman, MD||Yale University Department of Ophthalmology|